Project Details
Description
A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator s Choice in Participants with Chemotherapy-naive Metastatic Castration resistant Prostate Cancer
| Status | Active |
|---|---|
| Effective start/end date | 9/3/25 → 9/2/36 |
Funding
- AMGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.